Due to the current climate and imposed travel restrictions it can be difficult to carry out the necessary GMP inspections required to keep pharmaceutical supply chains in operation.

NSF’s pharmaceutical remote auditing service can help to unlock supply chains and meet cGMP needs in clinical trial supply or routine commercial operations. Using their network of international GMP experts, e-rooms and videoconferencing, NSF’s four-step process can help to provide interim or conditional approval of facilities during periods of uncertainty or governmental restrictions.

This risk-based approach can be applied to:

• Manufacturers of raw materials, GMP components, drug substances and drug products
• Packaging, warehousing and distribution facilities
• Contractors and QC release/stability testing

· And more Contact NSF at pharmamail@nsf.org or visit www.nsfpharma.org for more information